American Global Cancer Facts & Figures, 2nd Edition. http://www.cancer.org/research/cancerfactsfigures/globalcancerfactsfigures/global-facts-figures-2nd-ed. Accessed November 13, 2012.
Nyström L, Andersson I, Bjurstam N, Frisell BN, Nordenskjöld B, Rutgvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359:909-919. Abstract
Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med. 2002;137:305-312. Abstract
Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ. 1992;147:1477-1488. Abstract
Tabar L, Vitak B, Tony HH, Yen M-F, Duffy SW, Smith RA. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer. 2001;91:1724-1731. Abstract
Hellquist BN, Duffy SW, Abdsaleh S, et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years. Evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer. 2011;117:714-722. Abstract
Linver MN, Paster SB, Rosenberg RD, Key CR, Stidley CA, King WV. Improvement in mammography interpretation skills in a community radiology practice after dedicated teaching courses: 2-year medical audit of 38,633 cases. Radiology. 1992;184:39-43. Abstract
Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353:1773-1783. Abstract
Skaane P, Gullien R, Bjørndal H, et al. Digital breast tomosynthesis (DBT): initial experience in a clinical setting. Acta Radiol. 2012;53:524-529. Abstract
Berg WA, Zhang Z, Lehrer D, et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012;307:1394-1404. Abstract
Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75-89. Abstract
Podo F, Sardanelli F, Canese R, et al. The Italian Multi-Centre Project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res. 2002;21:115-124.
Kriege, M, Brekelmans CTM, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004;351:427-437. Abstract
Warner E, Plewes, DB, Hill KA, et al Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA. 2004;292:1317-1325. Abstract
Kuhl CK, Shrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging, for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005;23:8469-8476. Abstract
Lehman CD, Blume JD, Thickman D., et al. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol. 2005;92:9-16. Abstract
Leach M., Boggis CR, Dixon AK, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet. 2005;365:1769-1778. Abstract
Lehman CD, Isaacs C, Schnall MD, et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology. 2007;244:381-388. Abstract
Sardanelli F, Podo F, D'Agnolo G, et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT Study): interim results. Radiology. 2007;242:698-715. Abstract
Surveillance Epidemiology and End Results (SEER). http://seer.cancer.gov/csr/1975_2005/. Accessed November 13, 2012.
Allegra CJ, Aberle DR, Ganschow P, et al: National Institutes of Health state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ. J Natl Cancer Inst. 2010;102:161-169. Abstract
Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233:830-849. Abstract
Allen LR, Lago-Toro CE, Hughes JH, et al. Is there a role for MRI in the preoperative assessment of patients with DCIS? Ann Surg Oncol. 2010;17:2395-2400.
Schouten van der Velden AP, Boetes C, Bult P, Wobbes T. The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. Am J Surg. 2006;192:172-178. Abstract
Kuhl C, Weigel S, Schrading S, et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol. 2010;28:1450-1457. Abstract
Lee SG, Orel SG, Woo IJ, et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology. 2003;226:773-778. Abstract
Liberman L, Morris EA, Kim CM, et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol. 2003;180:333-341. Abstract
Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356:1295-1303. Abstract
Brennan S, Liberman L, Dershaw DD, Morris E. Breast MRI screening of women with a personal history of breast cancer. AJR Am J Roentgenol. 2010;195:510-516. Abstract
Orel SG, Weinstein SP, Schnall MD, et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology. 1999;212:543-549. Abstract
Morris EA, Schwartz LH, Dershaw DD, van Zee KJ, Abramson AF, Liberman L. MR imaging of the breast in patients with occult primary carcinoma. Radiology. 1997;205:437-440. Abstract
Henry-Tillman RS, Harms SE, Westbrook KC, Korourian S, Klimberg VS. Role of magnetic resonance imaging in determining breast as a source of unknown metastatic lymphadenopathy. Am J Surg. 1999;178:496-500. Abstract
ACR practice guideline for the performance of contrast-enhanced magnetic resonance imaging (MRI) of the breast. http://www.acr.org/~/media/2A0EB28EB59041E2825179AFB72EF624.pdf. Accessed November 13, 2012.
Jansen SA, Yang C, Shimauchi A, Fan X, Karczmar GS, Newstead GM. Relating dose of contrast media administered to uptake and washout of malignant lesions on DCEMR of the breast. Acad Radiol. 2010;17:24-30. Abstract
Ikeda DM. Updated breast MRI lexicon. Eur J Radiol. 2012;81:S63.
Jansen SA, Shimauchi A, Zak L, Fan X, Karczmar GS, Newstead GM. The diverse pathology and kinetics of mass, nonmass, and focus enhancement on MR imaging of the breast. J Magn Reson Imaging. 2011;33:1382-1389. Abstract
Edge SB, Byrd DR, Compton CC, et al, eds. AJCC Cancer Staging Manual. 7th ed. http://www.scribd.com/doc/76670620/AJCC-Cancer-Staging-Manual-7th-Edition. Accessed November 13, 2012.
Morris EA, Schwartz LH, Drotman MB, et al. Evaluation of pectoralis major muscle in patients with posterior breast tumors on breast MR images: early experience. Radiology. 2000;214:67-72. Abstract
Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008;26:3248-3258. Abstract
Boetes C, Mus RD, Holland R, et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology. 1995;197:743-747. Abstract
Mumtaz H, Hall-Craggs MA, Davidson T, et al. Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol. 1997;169:417-424. Abstract
Esserman L, Hylton N, Yassa L, Barclay J, Frankel S, Sickles E. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol. 1999;17:110-119. Abstract
Hollingsworth AB, Stough RG, O'Dell CA, Brekke CE. Breast magnetic resonance imaging for preoperative locoregional staging. Am J Surg. 2008;196:389-397. Abstract
Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356:1295-1303. Abstract
Slanetz PJ, Edmister WB, Yeh ED, Talele AC, Kopans DB. Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging. Breast J. 2002;8:145-148. Abstract
Mann, Hoogeveen YL, Blickman JG, Boetes C. MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Cancer Res Treat. 2008;107:1-14.
Quan ML, Sclafani MD, Heerdt AS, Fey JV, Morris EA, Borgen PI. Magnetic resonance imaging detects unsuspected disease in patients with invasive lobular cancer. Ann Surg Oncol. 2003;10:1048-1053. Abstract
Marpeau O, Ancel PY, Antoine M, Uzan S, Barranger E. Synchronous bilateral breast cancer: risk factors, diagnosis, histology and treatment. Gynecol Obstet Fertil. 2008;36:35-44. Abstract
Pediconi F, Catalano C, Roselli A. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions. Radiology. 2007;243:670-680. Abstract
Liberman L. Breast MR imaging in assessing extent of disease. Magn Reson Imaging Clin N Am. 2006;14:339-349. Abstract
Al Hallaq HA, Mell LK, Bradley JA, et al. Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients eligible for partial breast irradiation. Cancer. 2008;113:2408-2414. Abstract
Tendulkar MD, Chellman-Jeffers M, Rybicki LA, et al. Preoperative breast magnetic resonance imaging in early breast cancer: implications for partial breast irradiation. Cancer. 2009;115:1621-1630. Abstract
Li J, Dershaw DD, Lee CH, Joo S, Morris EA. Breast MRI after conservation therapy: usual findings in routine follow-up examinations. AJR Am J Roentgenol. 2010;195:799-807. Abstract
Warren RML, Bobrow LG, Earl HM, et al. Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy? Br J Cancer. 2004;90:1349-1360.
Hylton NM, Blume JD, Bernreuter WK, et al. Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from the ACRIN 6657/I-SPY TRIAL. Radiology. 2012;263:663-672. Abstract
Abe H, Schmidt RA, Shah RN, et al. MR-directed ("second-look") ultrasound examination for breast lesions detected initially on MRI: MR and sonographic findings. AJR Am J Roentgenol. 2010;194:370-377. Abstract
Rauch GM, Dogan BE, Smith TB, Liu P, Yang WT. Outcome analysis of 9-gauge MRI-guided vacuum-assisted core needle breast biopsies. AJR Am J Roentgenol. 2012;198:292-299. Abstract
Oxner CR, Vora L, Yim J, Kruper L, Ellenhorn JDI. Magnetic resonance imaging-guided breast biopsy in lesions not visualized by mammogram or ultrasound. Am Surg. 2012;78:1087-1090. Abstract
Bhooshan N, Giger ML, Jansen SA, Li H, Lan L, Newstead GM. Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers. Radiology. 2010;254:680-690. Abstract

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Author

Gillian Newstead, MD

Professor of Radiology, University of Chicago, and Clinical Director, Section of Breast Imaging, University of Chicago Medical Center, Chicago, Illinois

Disclosures

Disclosure: Gillian Newstead, MD, has disclosed the following financial relationships:
Served as an advisor or consultant for: Bayer Healthcare Pharmaceuticals, Bracco, and Three Palm Software, LLC
Received grants for clinical research from: Philips Healthcare Spouse owns stock in: Hologic, Inc.

Gillian Newstead, MD, does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Gillian Newstead, MD, does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editors

Jane Lowers

Group Scientific Director, Medscape, LLC

Disclosures

Disclosure: Jane Lowers has disclosed no relevant financial relationships.

Neil Chesanow

Senior Clinical Editor, Medscape, LLC

Disclosures

Disclosure: Neil Chesanow has disclosed no relevant financial relationships.

CME Reviewer

Nafeez Zawahir, MD

CME Clinical Director, Medscape, LLC

Disclosures

Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

CME

Breast Cancer Imaging: MRI’s Role in Current Practice

Authors: Gillian Newstead, MD
CME Released: 11/27/2012
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 11/27/2013, 11:59 PM EST

Start Activity

Target Audience and Goal Statement

This activity is intended for radiologists, oncologists, and gynecologists.

The goal of this activity is to discuss the role of magnetic resonance imaging (MRI) in breast cancer screening, staging, and treatment monitoring.

Upon completion of this activity, participants will be able to:

Compare the roles of mammography, ultrasound, and MRI in the diagnosis and staging of breast cancer
Propose imaging protocols to maximize sensitivity and specificity of breast MRI
Describe the role of MRI in treatment planning and monitoring for breast cancer

Disclosures

Author

Gillian Newstead, MD

Professor of Radiology, University of Chicago, and Clinical Director, Section of Breast Imaging, University of Chicago Medical Center, Chicago, Illinois

Disclosures

Disclosure: Gillian Newstead, MD, has disclosed the following financial relationships:
Served as an advisor or consultant for: Bayer Healthcare Pharmaceuticals, Bracco, and Three Palm Software, LLC
Received grants for clinical research from: Philips Healthcare Spouse owns stock in: Hologic, Inc.

Gillian Newstead, MD, does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Gillian Newstead, MD, does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editors

Jane Lowers

Group Scientific Director, Medscape, LLC

Disclosures

Disclosure: Jane Lowers has disclosed no relevant financial relationships.

Neil Chesanow

Senior Clinical Editor, Medscape, LLC

Disclosures

Disclosure: Neil Chesanow has disclosed no relevant financial relationships.

CME Reviewer

Nafeez Zawahir, MD

CME Clinical Director, Medscape, LLC

Disclosures

Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

Accreditation Statements

For Physicians

Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

processing....

Abbreviations

ACRIN = American College of Radiology Imaging Network
ACS = American Cancer Society
AJCC = American Joint Commission on Cancer
BI-RADS = Breast Imaging-Reporting and Data System
BPE = breast parenchymal enhancement
CAD = computer-aided diagnostics
CAVA = computer-aided visualization and analysis
CGN = Cancer Genetics Network
DCE-MRI = dynamic-contrast-enhanced magnetic resonance imaging
DCIS = ductal carcinoma in situ
DMIST = Digital Mammographic Imaging Screening Trial
IBMC = International Breast MRI Consortium
LCIS = lobular carcinoma in situ
ILC = invasive lobular cancer
IDC = invasive ductal cancer
MIP = maximum intensity projection
MPR = multiplanar reconstruction
MRI = magnetic resonance imaging
NME = nonmass enhancement
PPV = positive predictive value
RR = relative risk
TIC = time-intensity curve
TSE = turbo spin echo

« Return to: Breast Cancer Imaging: MRI’s Role in Current Practice

CME Information

Print
Like Tweet

References

Faculty and Disclosures

Author

Gillian Newstead, MD

Editors

Jane Lowers

Neil Chesanow

CME Reviewer

Nafeez Zawahir, MD

Peer Reviewer

CME

Breast Cancer Imaging: MRI’s Role in Current Practice

Target Audience and Goal Statement

Disclosures

Author

Gillian Newstead, MD

Editors

Jane Lowers

Neil Chesanow

CME Reviewer

Nafeez Zawahir, MD

Peer Reviewer

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Breast Cancer Imaging: MRI’s Role in Current Practice

Abbreviations